Dr. Nitanth Reddy Vangala, MD

Dr. Vangala practices at Chaparral Medical Group, Inc. in Pomona, California.

Dr. Vangala's NPI, 1861690141, was assigned on July 6, 2007. Dr. Vangala graduated from Wayne State University School Of Medicine in 2005. Dr. Vangala holds California license A97827.

Dr. Vangala's primary practice is Chaparral Medical Group, Inc., at 1866 N Orange Grove Ave, Pomona, CA 91767 in Los Angeles County. The practice phone is (909) 623-8796.

Dr. Vangala's primary practice is Chaparral Medical Group, Inc. in Pomona, California. Dr. Vangala is also affiliated with Pomona Valley Hospital Medical Center. The medical group on file is Chaparral Medical Group. Dmand AI also links Dr. Vangala to 2 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vangala practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Vangala's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Vangala is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Vangala's licenses on file in 2 states: California and Illinois.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and circulation problems among the conditions Dr. Vangala treats.

CMS data shows 3,732 Medicare services from Dr. Vangala across 26 procedure codes in 2024, for 1,117 Medicare patients. Medicare paid $391,955 for them.

CMS counts 1,117 Medicare patients who saw Dr. Vangala in 2024. The largest group is 65 to 74, with 422 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vangala's median patient age at 70, with 52% women.

In 2024, Dr. Vangala wrote 9,386 Medicare Part D claims for 1,246 patients. 81% of them were for generic drugs. CMS names the drug for 9,100 of them, across 65 drugs with 11 or more claims each, at $1,798,311 in total drug cost. In 2023, CMS named 7,417 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Vangala for performance year 2024, reported as part of a group. Dr. Vangala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vangala as offering telehealth. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Vangala, more than 33% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 271 general payments to Dr. Vangala from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Novartis Pharmaceuticals Corporation paid the most, $828.

Dr. Vangala graduated from Wayne State University School Of Medicine in 2005.

Dr. Vangala is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.